CRC
RARE icon

Curi RMB Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Curi RMB Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
+8,372
New +$208K ﹤0.01% 778
2021
Q2 		– Sell
-10,287
Closed -$1.17M – 473
2021
Q1 		$1.17M Sell
10,287
-18,402
-64% -$2.51M 0.04% 243
2020
Q4 		$3.97M Buy
28,689
+546
+2% +$64.8K 0.15% 146
2020
Q3 		$2.31M Buy
28,143
+1,459
+5% +$121K 0.1% 178
2020
Q2 		$2.09M Sell
26,684
-3,070
-10% -$203K 0.09% 198
2020
Q1 		$1.32M Buy
29,754
+476
+2% +$24.7K 0.06% 246
2019
Q4 		$1.25M Sell
29,278
-558
-2% -$23K 0.03% 336
2019
Q3 		$1.28M Buy
29,836
+3,033
+11% +$165K 0.03% 360
2019
Q2 		$1.7M Buy
26,803
+1,774
+7% +$113K 0.04% 340
2019
Q1 		$1.74M Hold
25,029
– – 0.04% 372
2018
Q4 		$1.09M Sell
25,029
-811
-3% -$44.3K 0.03% 484
2018
Q3 		$1.97M Sell
25,840
-2,513
-9% -$204K 0.05% 384
2018
Q2 		$2.18M Sell
28,353
-16,825
-37% -$1.09M 0.05% 360
2018
Q1 		$2.3M Buy
45,178
+1,445
+3% +$72.8K 0.06% 362
2017
Q4 		$2.03M Sell
43,733
-4,162
-9% -$204K 0.05% 377
2017
Q3 		$2.55M Buy
47,895
+8,470
+21% +$502K 0.07% 338
2017
Q2 		$2.45M Buy
+39,425
New +$2.38M 0.07% 340

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Curi RMB Capital's RARE Position: Q2 2026 in Review

Curi RMB Capital opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 8,372 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings. This is a return to the name: Curi RMB Capital previously reported a position in RARE as recently as Q1 2021.

Curi RMB Capital first reported a position in RARE in Q2 2017 and has held it in 17 quarters since. The position peaked at $3.97M in Q4 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Curi RMB Capital held 8,372 shares of Ultragenyx Pharmaceutical worth $280K as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Curi RMB Capital position in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Curi RMB Capital's portfolio in Q2 2026, its #778 holding.
  • Curi RMB Capital first reported a position in Ultragenyx Pharmaceutical in Q2 2017 and has held it in 17 quarters since.
  • Curi RMB Capital's Ultragenyx Pharmaceutical position peaked at $3.97M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.